Når der modtages ny information, der kan påvirke den aktuelle sikkerhedsspecifikation, pharmacovigilance- plan eller risikominimeringsaktiviteter
12 • When new information is received that may impact on the current Safety Specification, Pharmacovigilance Plan or risk minimisation activities